Can Pharma Defy Gravity at the Patent Cliff?

Can Pharma Defy Gravity at the Patent Cliff?

Filed under: drug abuse treatment cost analysis program

Generic-drug competition has become increasingly aggressive, especially in an environment where healthcare policies are placing stronger emphasis on pharmacoeconomics and demanding better treatment outcomes at a lower cost. A 2012 analysis by IMS …
Read more on Pharmaceutical Technology Magazine

Beyond 23andMe's Shutdown: The Role of the FDA in the Future of Direct-to …

Filed under: drug abuse treatment cost analysis program

The FDA worries that patients “may begin to self-manage their treatments through dose changes”: “For example, false genotype results for [23andMe's] warfarin drug response test could have significant unreasonable risk of illness, injury, or death to …
Read more on Practical Ethics (blog)

Drone-Hunting Vote Shot Down

Filed under: drug abuse treatment cost analysis program

The problem—he's got his facts wrong, and his small town is fighting back. As Amazon works to launch a fleet of … Hovering a few feet in the air, they'll watch, record, and analyze Americans' every move. Call yourself a non-smoker on your …
Read more on Daily Beast